Midatech Pharma (MTPH)

Company name:Midatech Pharma Plc
EPIC:MTPHTrading Currency:GBX
Market Sector:AMQ1ISIN:GB00BKT14T00
Market Segment:ASQ1Share Type:DE
WWW Address: 0.1P
 Price Price Change [%] Bid Ask Open High Low Volume
 8.75 0.0 [0.00] 8.50 9.00 8.75 8.75 8.75 190,250
 Market Cap. [m] Shares In Issue [m] Beta EPS DPS PE Ratio Yield 52-Wks-Range
 8.62 98.49 0.14 -7.00 - - - 26.50 - 8.20

Midatech Pharma Key Figures

(at previous day's close)
Market Cap.8.62m
Shares In Issue98.49m
Prev. Close8.75
PE Ratio- 
Dividend Yield-%
EPS - basic-7.00p
Dividend PS-p
Dividend Cover- 
Cash Flow PS-6.10p
Return On Equity (ROE)-52.24%
Operating Margin-1,056.40%
PEG Factor- 
EPS Growth Rate86.54%
Dividends PS Growth Rate-%
Net Debt-7.60m
Gross Gearing19.06%
Quick Assets11.76m
Net Working Capital9.92m
Intangibles / Fixed Assets-%
Turnover PS0.59p
Pre-Tax Profit PS-6.20p
Retained Profit PS-5.54p
Cash PS10.21p
Net Cash PS8.34p
Net Tangible Asset Value PS *10.61p
Net Asset Value PS10.61p
Spread0.50 (5.56%) 

Midatech Pharma Balance Sheet


Share Price Performance

Sample Period HighLow
1 week10.138.25
4 weeks12.758.25
12 weeks12.758.20
1 year26.508.20

Share Price Chart (5 years)

Midatech Pharma Historic Returns

Giorni da oggi OpenChange%Open Avg.Avg. Daily Vol [m]Total Vol [m]VWAP
1 week10.13-1.38-13.588.250.298.77
4 weeks11.50-2.75-23.918.250.2110.42
12 weeks9.00-0.25-2.788.200.1710.47
26 weeks12.75-4.00-31.378.200.2311.24
1 year26.25-17.50-66.678.200.1914.32
3 years51.25-42.50-82.931.900.4832.58
5 years720.00-711.25-98.781.900.5259.78

Midatech Pharma Key Management Ratios

Midatech Pharma Investment Ratios

(Market value analysis) at previous day's close
PQ Ratio- 
PE Ratio- 
Tobin's Q Ratio 0.76 
Tobin's Q Ratio (excl. intangibles)0.76 
Dividend Yield-%
Market-to-Book Ratio0.82 
Price-to-Pre-Tax Profit PS-1.41 
Price-to-Retained Profit PS-1.58 
Price-to-Cash Flow PS-1.43 
Price-to-Sales PS14.91 
Price-to-Net Tangible Asset Value PS0.82 
Price-to-Cash PS0.86 
Net Working Capital PS10.07 
Price Pct to Working Capital PS0.87%
Earnings Yield-%
Average PE2.40 
Years in average1 
PE to PE average-%

Midatech Pharma Financial Ratios

(Leverage Ratios)
Debt Ratio5.60%
Debt-to-Equity Ratio0.06 
Debt-to-Equity Ratio (excl. Intgbl)0.06 
Debt-to-Equity Market Value0.07 
Net Gearing-58.82%
Net Gearing (excl. Intangibles)-58.82%
Gross Gearing19.06%
Gross Gearing (excl. Intangibles)19.06%
Gearing Under 1 Year14.26%
Gearing Under 1 Year (excl. Intgbl)14.26%
(Liquidity Ratios)
Net Working Capital to Total Assets76.82%
Current Ratio6.39 
Quick Ratio (Acid Test)6.39 
Liquidity Ratio5.46 
Cash & Equiv/Current Assets85.51%
(Solvency Ratios)
Enterprise Value-0.82m
CFO/Attributable Profit- 
Total Debt/Equity Market Value0.29 
Total Debt/Sales4.26 
Total Debt/Pre-Tax Profit-0.40 
Total Debt2.46m
Total Debt/Net Current Assets0.25%
(Dodds - Graham Ratios)
3 yr Compound Earnings Growth-48.08%
5 yr Compound Earnings Growth-25.74%
10 yr Compound Earnings Growth-%
Earn drops > 5% in 10yrs3 
Beta (60-Mnth)Beta (36-Mnth)

Midatech Pharma Operating Ratios

(Profitability Ratios)
Return On Capital Employed (ROCE)-55.15%
Return On Assets (ROA)-48.04%
Net Profit Margin-944.64%
Assets Turnover0.05 
Return On Equity (ROE)-52.24%
Return On Investment (ROI)-61.01%
Dividend Payout Ratio-%
Plowback Ratio100.00%
Growth from Plowback Ratio-%
Net Income Of Revenues-944.64%
(Asset Utilisation Multiples)
Shareholders Equity Turnover0.07 
Fixed Assets Turnover0.68 
Current Assets Turnover0.05 
Net Working Capital Turnover 
Inventory Turnover- 
(Other Operating Ratios)
Total Assets-to-Sales19.66 
Debt Collection Period1,083.95Days

Midatech Pharma Dividends

Sorry No Data Available

Midatech Pharma Fundamentals

 31 Dec 2018 (GBP)31 Dec 2019 (GBP)31 Dec 2020 (GBP)31 Dec 2021 (GBP)
pre tax profit-12.40--10.92--23.47--6.11-m
attributable profit-15.03--10.09--23.19--5.46-m
retained profit-15.03--10.09--23.19--5.46-m
eps - basic (p)25.00 -50.00 -52.00 -7.00 
eps - diluted (p)25.00 -50.00 -52.00 -7.00 
dividends per share- - - - 

Midatech Pharma Balance Sheet

 31 Dec 2018 (GBP)31 Dec 2019 (GBP)31 Dec 2020 (GBP)31 Dec 2021 (GBP)
 31 Dec 2018 (GBP)31 Dec 2019 (GBP)31 Dec 2020 (GBP)31 Dec 2021 (GBP)
fixed assets fixed assets1.989.70%2.156.97%0.545.52%1.158.92%m
intangibles intangibles12.3760.53%12.3840.07%--%--%m
fixed investments fixed investments--%--%--%--%m
current assets - other current assets - other--%--%--%--%m
stocks stocks--%--%--%--%m
debtors debtors3.7418.31%5.4317.59%1.7317.61%1.7013.20%m
cash & securities cash & securities2.3411.46%10.9335.37%7.5576.87%10.0677.88%m
creditors - short creditors - short2.4712.09%5.6718.34%2.9930.45%1.8414.26%m
creditors - long creditors - long1.055.13%5.6718.35%0.111.12%0.624.80%m
creditors - other creditors - other--%--%--%--%m
subordinated loans subordinated loans--%--%--%--%m
insurance funds insurance funds--%--%--%--%m
ord cap, reserves ord cap, reserves16.9282.78%19.5663.30%6.7268.43%10.4580.94%m
prefs, minorities prefs, minorities--%--%--%--%m
NAV Basic- - - - 
NAV Diluted- - - - 

Midatech Pharma Cash Flow Statement

31 Dec 2018 (GBP)31 Dec 2019 (GBP)31 Dec 2020 (GBP)31 Dec 2021 (GBP)
Operating CF-13.45-6.49-9.30-6.01m
Pre-Financing CF-4.41-10.30-6.73-6.29m
Retained CF-10.888.44-3.642.52m

Midatech Pharma Brokers

Broker infomation is not available for this class of share.
Your Recent History
Midatech P..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now
NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:us D:20220927 10:49:18